Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Next-Gen Shopping App Introduces Aisle Sat-Nav, Facial Age-Verification, Queue-Less and Till-Less Checkout To The High Street

11/03/2020Next-Gen Shopping App Introduces Aisle Sat-Nav, Facial Age-Verification, Queue-Less and Till-Less Checkout To The High Street

Ubamarket is the only tech of its kind to increase purchases and secure more footfall for high street retailers. This is a much-needed solution amidst the decline of the UK retail industry following the rise of e-commerce, which has seen large quantities of cu

Why GDPR is Good for Your Business

04/06/2018Why GDPR is Good for Your Business

Christopher Scott, programme director at The Bunker, talks us through the benefits of GDPR now it is in full force.

School of Success: 6 Things Business Owners Can Learn from Teachers

Corporate Social Responsibility

05/06/2024School of Success: 6 Things Business Owners Can Learn from Teachers

Business and teaching are too often viewed as opposites or, at best, distant cousins when they actually have to lot in common. The biggest thing many of us don’t realise or have forgotten?

The Stretch Zone, Deep Learning from the Inside-Out

08/06/2016The Stretch Zone, Deep Learning from the Inside-Out

I recently had the pleasure of meeting Richard, COO at a financial services organisation. We first met ten years ago on a talent and leadership programme where I was lead facilitator.

Haskell Acquires Leidos Constructors and Design Assets

16/03/2016Haskell Acquires Leidos Constructors and Design Assets

Haskell, one of the leading fully integrated design, engineering and construction firms, announced today that it has signed a definitive agreement to acquire Leidos Constructors, LLC.

Some Clever Ways To Save Money As a Startup in 2024

09/08/2024Some Clever Ways To Save Money As a Startup in 2024

Running a startup often comes with lots of excitement and energy and if you have raised some initial capital, you may be inclined to spend it to grow. But with most startups that are not revenue making in their first few years, this capital can run out pretty

The Business Case for Better UK Paternity Laws

17/07/2024The Business Case for Better UK Paternity Laws

It’s no secret that more and more of us are choosing not to have children. The UK birth rate has declined to the lowest levels in over a decade, while the average age of parents has hit a record high.

Retail MVNOs Enter a New Loyalty Era

07/07/2026Retail MVNOs Enter a New Loyalty Era

Retail’s relationship with telecoms is entering a more commercially integrated phase.

Ones to Watch for 2016: The Leading Tax Experts

05/05/2016Ones to Watch for 2016: The Leading Tax Experts

ARN HOXTON is a boutique accounting firm based in the city of London, primarily offering services to small and medium sized businesses.

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS